儿童慢性肾脏病中的基因组疾病与神经认知功能损害
基于CKiD研究数据,比较携带基因组疾病(n=31)与非携带者(n=389)的CKD患儿在入组时的神经认知表现。携带者在所有智力、焦虑/抑郁症状及执行功能测量上得分显著更差(差异0.6-0.7个标准差;P=1.2×10⁻³至2.4×10⁻⁴),控制已知修饰因素后差异持续存在。母亲受教育程度较高可显著减弱基因组疾病对神经认知功能的不良影响。
要点
- 携带基因组疾病的CKD患儿神经认知表现显著差于非携带者,差异为0.6-0.7个标准差。
- 控制低出生体重、母亲教育、癫痫、肾病病程及遗传 ancestry 后差异仍持续存在。
- 母亲受教育程度较高可显著减弱基因组疾病对神经认知功能的不良影响。
核心结论
- 部分CKD患儿的神经认知功能损害可能归因于同时影响肾脏和神经认知发育的遗传病变。
- 早期识别基因组疾病可能为早期诊断和个性化干预提供机会,以减轻对神经认知功能的影响。
研究设计与样本
- 基于CKD in Children(CKiD)研究数据,比较携带基因组疾病(n=31)与非携带者(n=389)的CKD患儿在入组时的神经认知表现。
主要发现
- 与非携带者(n=389)相比,携带基因组疾病的儿童(n=31)在所有智力、焦虑/抑郁症状及执行功能测量上得分显著更差(差异0.6-0.7个标准差;P=1.2×10⁻³至2.4×10⁻⁴)。
- 控制已知修饰因素(包括低出生体重、母亲教育、癫痫、肾病病程及遗传定义 ancestry)后,这些差异持续存在。
- 基因组疾病对神经认知功能的不良影响在母亲受教育程度较高的子代中显著减弱,提示可能受遗传和/或环境因素修饰。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Children with CKD are at increased risk for neurocognitive impairment, but whether neurocognitive dysfunction is solely attributable to impaired renal function is unclear. Data from the CKD in Children Study Chronic Kidney Disease in Children (CKiD) Study indicate that a subset of children with CKD have unsuspected genomic disorders that predispose them to organ malformations and neurocognitive impairment. We therefore tested whether the CKiD Study participants with genomic disorders had impaired neurocognitive performance at enrollment. Compared with noncarriers (n=389), children with genomic disorders (n=31) scored significantly poorer on all measures of intelligence, anxiety/depressive symptoms, and executive function (differences of 0.6-0.7 SD; P=1.2×10-3-2.4×10-4). These differences persisted after controlling for known modifiers, including low birth weight, maternal education, seizure disorder, kidney disease duration, and genetically defined ancestry. The deleterious effect of genomic disorders on neurocognitive function was significantly attenuated in offspring of mothers with higher education, indicating the potential for modification by genetic and/or environmental factors. These data indicate that impaired neurocognitive function in some children with CKD may be attributable to genetic lesions that affect both kidney and neurocognitive development. Early identification of genomic disorders may provide opportunity for early diagnosis and personalized interventions to mitigate the effect on neurocognitive function.
引用
- Verbitsky M, Kogon AJ, Matheson M, et al. Genomic Disorders and Neurocognitive Impairment in Pediatric CKD. J Am Soc Nephrol. 2017. PMID: 28348065. doi:10.1681/ASN.2016101108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。